Complimentary Health Affairs Symposium: Promoting Innovation & Equity As COVID-19 Vaccines & Treatment Emerge, August 24, 2020

  • Date: Monday, August 24, 2020
  • Time: 1:00 p.m. - 4:00 p.m.
  • Place: Online details to be shared after registration

Debbie Boylan
Phone: 301-347-3910

As scientists and clinicians race to develop effective treatments to improve survival from COVID-19 and a vaccine to control the SARS-CoV-2 virus, Health Affairs has launched a new project to help identify for policy makers the critical decisions they will face that will have a substantial effect on whether and how quickly society reaps the benefits of these advances.

You are invited to join us on Monday, August 24, for a virtual symposium when some of the top minds in the field will join Health Affairs Editor-in-Chief Alan Weil for a discussion of these issues. Segments will focus on "Innovation" and "Equitable Access to Vaccines and Therapeutics."

Date: Monday, August 24, 2020
Time: 1:00 p.m. - 4:00 p.m.
Place: Online details to be shared after registration


Phyllis Arthur, MBA
Vice President, Infectious Diseases & Diagnostics Policy, Biotechnology Innovation Organization (BIO), Former Senior Director, Regional Pediatric Specialty Sales, Merck, Washington, DC

Rena M. Conti
Dean's Research Scholar, Questrom School of Business, Boston University, Associate Professor, Markets, Public Policy, Law Associate Research Director, Institute For Health System Innovation And Policy, Boston, MA

David Feinberg, MD, MBA
Vice President, Google Health, Former President and CEO, Geisinger, Former President & CEO, UCLA Health, San Francisco, CA

Garth Graham, MD, MPH
Vice President and Chief Community Health Officer, CVS Health, Associate Professor, University of Connecticut Medical School, Former Vice President of Community Health, Aetna, Hartford, CN

Margaret A. Hamburg, MD
President-elect, American Association for the Advancement of Science (AAAS), National Academy of Science, Engineering and Medicine, National Academy of Medicine, Former Commissioner, US Food and Drug Administration, Washington, DC

Orin Levine, PhD
Director, Global Delivery Programs, Bill & Melinda Gates Foundation, Seattle, WA

Nicole Lurie, MD, MSPH
Strategic Advisor to the CEO, CEPI; Senior Lecturer, Harvard Medical School, Former Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services, Boston, MA

Angela K. Shen, ScD, MPH
Visiting Research Scientist, Vaccine Education Center, Children’s Hospital of Philadelphia, Captain (Ret.), US Public Health Services, Former Senior Science Policy Advisor, US Department of Health and Human Services, Philadelphia, PA

Rebecca Lynn Weintraub
Assistant Professor of Medicine, Assistant Professor of Global Health and Social Medicine, Harvard Medical School, Faculty Director, Global Health Delivery Project, Harvard University, Boston, MA

Gavin Mark Yamey, MPH
Professor, Practice of Global Health, Sanford School of Public Policy, Duke University, Associate of the Duke Initiative for Science & Society, Core Faculty Member, Duke-Margolis Center for Health Policy, Durham, NC
Others to be announced

Health Affairs is grateful to the following sponsors for their support of this work and this symposium:

Anthem, Inc., Amgen Inc., Avalere, Kaiser Permanente, Pharmaceutical Research and Manufacturers of America (PhRMA), Gilead, McKesson, Quest Diagnostics, Dynavax, Alexion, and Danaher.


Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through, Health Affairs Today, and Health Affairs Sunday Update.

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.